Jsb Market Research : Pediatric Interventional Cardiology Market by Congenital Heart Defect Closure Device & Procedures Global Forecasts to 2018
- Submitted by: richa21
- Views: 393
- Category: Other
- Date Submitted: 09/03/2014 10:20 PM
- Pages: 13
- Report this Essay
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures Global Forecasts to 2018
Released On 4th September 2014
The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.
In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births....
Released On 4th September 2014
The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.
In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births....